We are currently conducting research into the potential use of Omnigen® (a dry preserved biological matrix, derived from human amnion) in the treatment of Diabetic Foot Ulcers (DFUs).
As part of this research we would like to gain a better understanding of the pathway for new products into this market. Please could you could spare 4 minutes of your time to complete a quick survey? If so, please click on the link below
Earlier this month, the government unveiled its latest commitment to accelerate access to cancer treatments through a so-called "red tape blitz". Headlines have trumpeted a simplified approval process for innovative therapies, claiming this will bring game-changing...
The OrQA-UK trial, a major research study aiming to reduce the number of donated organs that go unused, has been awarded funding by the National Institute for Health and Care Research (NIHR). The OrQA tool uses Artificial Intelligence (AI) to help assess donor livers,...
I am a proud believer in the NHS and its fundamental principles: treatment free at the point of care, equality in access, and fairness. However, my professional experiences increasingly highlight a worrying reality - Britain now operates a two-tier healthcare...